π COMPARISON TABLE β KFT vs. LFT
Parameter | Kidney Function Test (KFT) | Liver Function Test (LFT) |
---|---|---|
Main Organs Assessed | Kidneys | Liver |
Primary Role | Excretion of waste, electrolyte & fluid balance | Metabolism, detoxification, bile production |
Key Markers | Creatinine, BUN, GFR, Electrolytes | Bilirubin, ALT, AST, ALP, Albumin, INR |
Disease Indications | CKD, AKI, Nephrotic Syndrome, Glomerulonephritis | Hepatitis, Cirrhosis, Liver Failure, Fatty Liver |
Common Symptoms | Edema, Hypertension, Oliguria, Metabolic Acidosis | Jaundice, Fatigue, Ascites, RUQ Pain |
π HOW TO USE KFT & LFT TOGETHER IN CLINICAL PRACTICE
1οΈβ£ Assessing Multi-Organ Failure β In sepsis or shock, both kidneys and liver may be affected.
2οΈβ£ Differentiating Edema Causes β Renal edema (nephrotic syndrome) vs Liver-related edema (cirrhosis, hypoalbuminemia).
3οΈβ£ Detecting Drug Toxicity β Medications like NSAIDs, antibiotics, or chemotherapy can affect both organs.
4οΈβ£ Investigating Electrolyte Imbalances β Liver dysfunction can lead to renal complications (hepatorenal syndrome).
5οΈβ£ Screening for Systemic Disorders β Conditions like autoimmune diseases, infections, and metabolic syndromes affect both liver & kidney.
π΄ CASE 1: CHRONIC LIVER DISEASE (CIRRHOSIS) WITH HEPATORENAL SYNDROME (HRS)
π Clinical Presentation:
A 58-year-old male with a history of alcohol use and cirrhosis presents with jaundice, abdominal distension, confusion, and reduced urine output.
πΉ LFT & KFT REPORTS:
Parameter | Value | Normal Range | Interpretation |
---|---|---|---|
Serum Bilirubin (Total) | 7.2 mg/dL | 0.1 – 1.2 mg/dL | Severe jaundice |
ALT (SGPT) | 58 U/L | 7 – 56 U/L | Mild elevation |
AST (SGOT) | 98 U/L | 10 – 40 U/L | Alcoholic liver damage |
Albumin | 2.3 g/dL | 3.5 – 5.5 g/dL | Low β Edema/Ascites |
INR (Prothrombin Time) | 2.1 | <1.2 | Liver failure β Coagulopathy |
Creatinine | 2.5 mg/dL | 0.6 – 1.2 mg/dL | Kidney failure (AKI on CKD) |
BUN | 55 mg/dL | 7 – 20 mg/dL | High |
GFR | 25 mL/min | >90 mL/min | Chronic kidney damage |
Sodium (NaβΊ) | 125 mEq/L | 135 – 145 mEq/L | Hyponatremia |
πΉ Interpretation:
- LFT shows cirrhosis β High Bilirubin, Low Albumin, High INR
- KFT shows kidney failure β High Creatinine & Low GFR
- Diagnosis: Hepatorenal Syndrome (HRS) β Liver failure leading to kidney dysfunction
πΉ Management:
β
Albumin infusion + Terlipressin for HRS
β
Dialysis for worsening kidney function
β
Liver transplant evaluation
π΅ CASE 2: SEPSIS-INDUCED MULTI-ORGAN FAILURE (LIVER + KIDNEYS)
π Clinical Presentation:
A 65-year-old diabetic female with fever, confusion, and low blood pressure due to septic shock (E. coli UTI & bacteremia).
πΉ LFT & KFT REPORTS:
Parameter | Value | Normal Range | Interpretation |
---|---|---|---|
Serum Bilirubin | 5.0 mg/dL | 0.1 – 1.2 mg/dL | Sepsis-induced liver dysfunction |
ALT (SGPT) | 122 U/L | 7 – 56 U/L | Liver injury (shock liver) |
AST (SGOT) | 210 U/L | 10 – 40 U/L | High (ischemic hepatitis) |
INR | 2.3 | <1.2 | Coagulopathy β Sepsis-related DIC |
Creatinine | 4.0 mg/dL | 0.6 – 1.2 mg/dL | Acute Kidney Injury (Sepsis-induced AKI) |
BUN | 85 mg/dL | 7 – 20 mg/dL | Severe AKI |
Lactate | 4.5 mmol/L | <2.0 mmol/L | Septic Shock |
πΉ Interpretation:
- Septic Shock β Multi-organ failure affecting both Liver & Kidneys
- Shock Liver (ischemic hepatitis) β Elevated AST & ALT
- Acute Kidney Injury (AKI) β High Creatinine & BUN due to sepsis
- Coagulopathy (DIC) β High INR β Risk of bleeding
πΉ Management:
β
IV fluids + Broad-spectrum antibiotics
β
Vasopressors for BP support
β
Dialysis for severe AKI
β
Close monitoring of INR & liver function
π’ CASE 3: DRUG-INDUCED HEPATOTOXICITY + RENAL IMPAIRMENT (ACETAMINOPHEN TOXICITY)
π Clinical Presentation:
A 30-year-old male with a history of overdose on acetaminophen (paracetamol) presents with nausea, RUQ pain, confusion, and oliguria.
πΉ LFT & KFT REPORTS:
Parameter | Value | Normal Range | Interpretation |
---|---|---|---|
Serum Bilirubin | 3.5 mg/dL | 0.1 – 1.2 mg/dL | Liver injury |
ALT (SGPT) | 870 U/L | 7 – 56 U/L | Massive Hepatocellular Damage |
AST (SGOT) | 920 U/L | 10 – 40 U/L | Severe Liver Necrosis |
Creatinine | 3.2 mg/dL | 0.6 – 1.2 mg/dL | Acute Kidney Injury (AKI) |
BUN | 50 mg/dL | 7 – 20 mg/dL | Acute Renal Dysfunction |
πΉ Interpretation:
- Hepatic failure due to drug-induced hepatotoxicity (Paracetamol OD)
- Acute Kidney Injury secondary to toxin metabolism
- Severe transaminase elevation (ALT & AST > 500) β Drug-induced hepatitis
πΉ Management:
β
N-Acetylcysteine (NAC) antidote
β
Supportive care for AKI
β
Liver transplant evaluation if worsening
π WHEN TO ORDER KFT & LFT TOGETHER?
πΉ Suspected Multi-Organ Failure (Sepsis, Shock, Toxin ingestion)
πΉ Severe Edema (Nephrotic vs. Cirrhosis-related)
πΉ Electrolyte Abnormalities with Liver Disease
πΉ Drug Toxicity (NSAIDs, Antibiotics, Acetaminophen, Alcohol)
πΉ